Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Box C/D snoRNA protein 1 (Serologically defined breast cancer antigen NY-BR-75) (Zinc finger HIT domain-containing protein 6)

 BCD1_HUMAN              Reviewed;         470 AA.
Q9NWK9; B2RBA1; B4DP13; D3DT20; Q9H278; Q9H3X3; Q9NWN0;
20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
01-OCT-2000, sequence version 1.
10-OCT-2018, entry version 130.
RecName: Full=Box C/D snoRNA protein 1;
AltName: Full=Serologically defined breast cancer antigen NY-BR-75;
AltName: Full=Zinc finger HIT domain-containing protein 6;
Name=ZNHIT6; Synonyms=BCD1, C1orf181;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
TISSUE=Hepatoma, and Testis;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Testis;
PubMed=17974005; DOI=10.1186/1471-2164-8-399;
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
"The full-ORF clone resource of the German cDNA consortium.";
BMC Genomics 8:399-399(2007).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16710414; DOI=10.1038/nature04727;
Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
Beck S., Rogers J., Bentley D.R.;
"The DNA sequence and biological annotation of human chromosome 1.";
Nature 441:315-321(2006).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Testis;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
NUCLEOTIDE SEQUENCE [MRNA] OF 69-470 (ISOFORM 1).
TISSUE=Mammary gland;
PubMed=12747765;
Scanlan M.J., Gout I., Gordon C.M., Williamson B., Stockert E.,
Gure A.O., Jaeger D., Chen Y.-T., Mackay A., O'Hare M.J., Old L.J.;
"Humoral immunity to human breast cancer: antigen definition and
quantitative analysis of mRNA expression.";
Cancer Immun. 1:4-4(2001).
[7]
FUNCTION, AND INTERACTION WITH FBL; SNU13; NOP58; NUFIP1; RUVBL1;
RUVBL2 AND TAF9.
PubMed=17636026; DOI=10.1128/MCB.01097-07;
McKeegan K.S., Debieux C.M., Boulon S., Bertrand E., Watkins N.J.;
"A dynamic scaffold of pre-snoRNP factors facilitates human box C/D
snoRNP assembly.";
Mol. Cell. Biol. 27:6782-6793(2007).
[8]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18669648; DOI=10.1073/pnas.0805139105;
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[9]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma, and Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Liver;
PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
Wang L., Ye M., Zou H.;
"An enzyme assisted RP-RPLC approach for in-depth analysis of human
liver phosphoproteome.";
J. Proteomics 96:253-262(2014).
[11]
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-143; LYS-162; LYS-200 AND
LYS-459, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
PubMed=25218447; DOI=10.1038/nsmb.2890;
Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
Vertegaal A.C.;
"Uncovering global SUMOylation signaling networks in a site-specific
manner.";
Nat. Struct. Mol. Biol. 21:927-936(2014).
[12]
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-138 AND LYS-200, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=25755297; DOI=10.1074/mcp.O114.044792;
Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
Vertegaal A.C.;
"System-wide analysis of SUMOylation dynamics in response to
replication stress reveals novel small ubiquitin-like modified target
proteins and acceptor lysines relevant for genome stability.";
Mol. Cell. Proteomics 14:1419-1434(2015).
[13]
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-79; LYS-108; LYS-118;
LYS-138; LYS-143; LYS-153; LYS-162; LYS-173; LYS-183; LYS-200 AND
LYS-459, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
PubMed=28112733; DOI=10.1038/nsmb.3366;
Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
Nielsen M.L.;
"Site-specific mapping of the human SUMO proteome reveals co-
modification with phosphorylation.";
Nat. Struct. Mol. Biol. 24:325-336(2017).
[14]
VARIANT [LARGE SCALE ANALYSIS] HIS-455.
PubMed=16959974; DOI=10.1126/science.1133427;
Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
Vogelstein B., Kinzler K.W., Velculescu V.E.;
"The consensus coding sequences of human breast and colorectal
cancers.";
Science 314:268-274(2006).
-!- FUNCTION: Required for box C/D snoRNAs accumulation involved in
snoRNA processing, snoRNA transport to the nucleolus and ribosome
biogenesis. {ECO:0000269|PubMed:17636026}.
-!- SUBUNIT: Interacts with FBL, SNU13, NOP58, NUFIP1, RUVBL1, RUVBL2
and TAF9. {ECO:0000269|PubMed:17636026}.
-!- INTERACTION:
Q9UHK0:NUFIP1; NbExp=2; IntAct=EBI-2563515, EBI-2563549;
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=Q9NWK9-1; Sequence=Displayed;
Name=2;
IsoId=Q9NWK9-2; Sequence=VSP_042946;
Note=No experimental confirmation available.;
-!- SIMILARITY: Belongs to the BCD1 family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=AAG48263.1; Type=Frameshift; Positions=365, 412, 416, 419, 432; Evidence={ECO:0000305};
Sequence=BAA91349.1; Type=Erroneous initiation; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AK000736; BAA91349.1; ALT_INIT; mRNA.
EMBL; AK000767; BAA91371.1; -; mRNA.
EMBL; AK298149; BAG60425.1; -; mRNA.
EMBL; AK314566; BAG37148.1; -; mRNA.
EMBL; AL442074; CAC09440.1; -; mRNA.
EMBL; AC092807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AC099561; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BX323040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471097; EAW73194.1; -; Genomic_DNA.
EMBL; CH471097; EAW73195.1; -; Genomic_DNA.
EMBL; BC026236; AAH26236.1; -; mRNA.
EMBL; BC110898; AAI10899.1; -; mRNA.
EMBL; AF308296; AAG48263.1; ALT_FRAME; mRNA.
CCDS; CCDS53338.1; -. [Q9NWK9-2]
CCDS; CCDS707.1; -. [Q9NWK9-1]
RefSeq; NP_001164141.1; NM_001170670.1. [Q9NWK9-2]
RefSeq; NP_060423.3; NM_017953.3. [Q9NWK9-1]
UniGene; Hs.5111; -.
ProteinModelPortal; Q9NWK9; -.
SMR; Q9NWK9; -.
BioGrid; 120099; 27.
IntAct; Q9NWK9; 9.
MINT; Q9NWK9; -.
STRING; 9606.ENSP00000359606; -.
iPTMnet; Q9NWK9; -.
PhosphoSitePlus; Q9NWK9; -.
BioMuta; ZNHIT6; -.
DMDM; 74753026; -.
EPD; Q9NWK9; -.
MaxQB; Q9NWK9; -.
PaxDb; Q9NWK9; -.
PeptideAtlas; Q9NWK9; -.
PRIDE; Q9NWK9; -.
ProteomicsDB; 82943; -.
ProteomicsDB; 82944; -. [Q9NWK9-2]
DNASU; 54680; -.
Ensembl; ENST00000370574; ENSP00000359606; ENSG00000117174. [Q9NWK9-1]
Ensembl; ENST00000431532; ENSP00000414344; ENSG00000117174. [Q9NWK9-2]
GeneID; 54680; -.
KEGG; hsa:54680; -.
UCSC; uc001dlh.4; human. [Q9NWK9-1]
CTD; 54680; -.
DisGeNET; 54680; -.
EuPathDB; HostDB:ENSG00000117174.10; -.
GeneCards; ZNHIT6; -.
H-InvDB; HIX0000749; -.
HGNC; HGNC:26089; ZNHIT6.
HPA; HPA018132; -.
neXtProt; NX_Q9NWK9; -.
OpenTargets; ENSG00000117174; -.
PharmGKB; PA162410929; -.
eggNOG; KOG2858; Eukaryota.
eggNOG; ENOG4111QF2; LUCA.
GeneTree; ENSGT00390000017201; -.
HOGENOM; HOG000054208; -.
HOVERGEN; HBG102997; -.
InParanoid; Q9NWK9; -.
OMA; MSRCETC; -.
OrthoDB; EOG091G0E2X; -.
PhylomeDB; Q9NWK9; -.
TreeFam; TF323923; -.
ChiTaRS; ZNHIT6; human.
GenomeRNAi; 54680; -.
PRO; PR:Q9NWK9; -.
Proteomes; UP000005640; Chromosome 1.
Bgee; ENSG00000117174; Expressed in 220 organ(s), highest expression level in brain.
CleanEx; HS_ZNHIT6; -.
Genevisible; Q9NWK9; HS.
GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
GO; GO:0070761; C:pre-snoRNP complex; IDA:BHF-UCL.
GO; GO:0051117; F:ATPase binding; IPI:UniProtKB.
GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
GO; GO:0042802; F:identical protein binding; IPI:BHF-UCL.
GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
GO; GO:0001094; F:TFIID-class transcription factor binding; IPI:UniProtKB.
GO; GO:0000492; P:box C/D snoRNP assembly; IMP:BHF-UCL.
GO; GO:0051259; P:protein complex oligomerization; IMP:UniProtKB.
GO; GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW.
GO; GO:0048254; P:snoRNA localization; IMP:UniProtKB.
InterPro; IPR007529; Znf_HIT.
Pfam; PF04438; zf-HIT; 1.
PROSITE; PS51083; ZF_HIT; 1.
1: Evidence at protein level;
Alternative splicing; Complete proteome; Isopeptide bond;
Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
Ribosome biogenesis; Ubl conjugation; Zinc; Zinc-finger.
CHAIN 1 470 Box C/D snoRNA protein 1.
/FTId=PRO_0000280239.
ZN_FING 220 254 HIT-type. {ECO:0000255|PROSITE-
ProRule:PRU00453}.
COMPBIAS 40 202 Glu-rich.
MOD_RES 25 25 Phosphoserine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:23186163,
ECO:0000244|PubMed:24275569}.
CROSSLNK 79 79 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:28112733}.
CROSSLNK 108 108 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:28112733}.
CROSSLNK 118 118 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:28112733}.
CROSSLNK 138 138 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:25755297,
ECO:0000244|PubMed:28112733}.
CROSSLNK 143 143 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:25218447,
ECO:0000244|PubMed:28112733}.
CROSSLNK 153 153 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:28112733}.
CROSSLNK 162 162 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:25218447,
ECO:0000244|PubMed:28112733}.
CROSSLNK 173 173 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:28112733}.
CROSSLNK 183 183 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:28112733}.
CROSSLNK 200 200 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:25218447,
ECO:0000244|PubMed:25755297,
ECO:0000244|PubMed:28112733}.
CROSSLNK 459 459 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:25218447,
ECO:0000244|PubMed:28112733}.
VAR_SEQ 78 116 Missing (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_042946.
VARIANT 9 9 G -> R (in dbSNP:rs17399721).
/FTId=VAR_031096.
VARIANT 455 455 L -> H (in a colorectal cancer sample;
somatic mutation).
{ECO:0000269|PubMed:16959974}.
/FTId=VAR_035721.
CONFLICT 144 144 E -> G (in Ref. 2; CAC09440).
{ECO:0000305}.
SEQUENCE 470 AA; 53918 MW; 34A50A1C62E4F4E8 CRC64;
MEFAAENEGK SGGGLHSVAE GVRLSPEPGR EGVRDLAGAE EFGGGEEGTG LTGIKEIGDG
EEGSGQRPEE IPMDLTVVKQ EIIDWPGTEG RLAGQWVEQE VEDRPEVKDE NAGVLEVKQE
TDSSLVVKEA KVGEPEVKEE KVKEEVMDWS EVKEEKDNLE IKQEEKFVGQ CIKEELMHGE
CVKEEKDFLK KEIVDDTKVK EEPPINHPVG CKRKLAMSRC ETCGTEEAKY RCPRCMRYSC
SLPCVKKHKA ELTCNGVRDK TAYISIQQFT EMNLLSDYRF LEDVARTADH ISRDAFLKRP
ISNKYMYFMK NRARRQGINL KLLPNGFTKR KENSTFFDKK KQQFCWHVKL QFPQSQAEYI
EKRVPDDKTI NEILKPYIDP EKSDPVIRQR LKAYIRSQTG VQILMKIEYM QQNLVRYYEL
DPYKSLLDNL RNKVIIEYPT LHVVLKGSNN DMKVLHQVKS ESTKNVGNEN


Related products :

Catalog number Product name Quantity
EIAAB06964 C6orf204,Coiled-coil domain-containing protein C6orf204,Homo sapiens,Human,Serologically defined breast cancer antigen NY-BR-15
EIAAB05210 CALML4,Calmodulin-like protein 4,Homo sapiens,Human,Serologically defined breast cancer antigen NY-BR-20
EIAAB31864 Homo sapiens,Human,KEPI,Kinase-enhanced PP1 inhibitor,PKC-potentiated PP1 inhibitory protein,PPP1R14C,Protein phosphatase 1 regulatory subunit 14C,Serologically defined breast cancer antigen NY-BR-81
EIAAB40640 C9orf13,CCP module-containing protein 22,CCP22,Homo sapiens,Human,Polydom,Selectin-like osteoblast-derived protein,SELOB,SEL-OB,Serologically defined breast cancer antigen NY-BR-38,Sushi, von Willebra
EIAAB13227 Endoplasmic reticulum-Golgi intermediate compartment protein 3,Ergic3,Erv46,Mouse,Mus musculus,Sdbcag84,Serologically defined breast cancer antigen NY-BR-84 homolog
18-003-42556 Serologically defined breast cancer antigen NY-BR-75 - N_A Polyclonal 0.1 mg Protein A
EIAAB13226 C20orf47,CGI-54,Endoplasmic reticulum-Golgi intermediate compartment protein 3,ERGIC3,ERV46,Homo sapiens,Human,PRO0989,SDBCAG84,Serologically defined breast cancer antigen NY-BR-84
EIAAB30217 Antigen NY-CO-28,CGI-52,Homo sapiens,Human,PCTP-L,PCTP-like protein,SDCCAG28,Serologically defined colon cancer antigen 28,StARD10,STARD10,StAR-related lipid transfer protein 10,START domain-containin
EIAAB38146 Homo sapiens,hSgo1,Human,Serologically defined breast cancer antigen NY-BR-85,SGO1,SGOL1,Shugoshin-like 1
EIAAB32490 Homo sapiens,hPrp31,Human,Pre-mRNA-processing factor 31,Protein 61K,PRP31,PRPF31,Serologically defined breast cancer antigen NY-BR-99,U4_U6 small nuclear ribonucleoprotein Prp31,U4_U6 snRNP 61 kDa pro
EIAAB37719 Antigen NY-CO-8,CCCAP,Centrosomal colon cancer autoantigen protein,hCCCAP,Homo sapiens,HSPC085,Human,SDCCAG8,Serologically defined colon cancer antigen 8
EIAAB30218 Mouse,Mus musculus,Pctpl,PCTP-L,PCTP-like protein,Sdccag28,Sdccagg28,Serologically defined colon cancer antigen 28 homolog,StARD10,Stard10,StAR-related lipid transfer protein 10,START domain-containin
EIAAB45482 Antigen NY-CO-16,Homo sapiens,Human,SDCCAG16,Serologically defined colon cancer antigen 16,U3 small nucleolar RNA-associated protein 14 homolog A,UTP14A
EIAAB37718 Cccap,Centrosomal colon cancer autoantigen protein,mCCCAP,Mouse,Mus musculus,Sdccag8,Serologically defined colon cancer antigen 8 homolog
EIAAB40402 Homo sapiens,Human,LYK5,Serologically defined breast cancer antigen NY-BR-96,STE20-related adapter protein,STE20-related kinase adapter protein alpha,STRAD,STRAD alpha,STRADA
EIAAB47194 Homo sapiens,Human,Zf47,ZFP47,Zfp-47,Zinc finger and SCAN domain-containing protein 13,Zinc finger protein 306,Zinc finger protein 309,Zinc finger protein 47 homolog,Zinc finger protein with KRAB and
EIAAB46826 FANCC-interacting protein,Fanconi anemia zinc finger protein,FAZF,Homo sapiens,Human,Testis zinc finger protein,TZFP,ZBTB32,Zinc finger and BTB domain-containing protein 32,Zinc finger protein 538,ZNF
E6107h Human Serologically Defined Colon Cancer Antigen 1 96T
EH1858 Serologically defined colon cancer antigen 3 Elisa Kit 96T
E6106h Human Serologically Defined Colon Cancer Antigen 1 96T
E5544h Human Serologically Defined Colon Cancer Antigen 8 96T
201-20-5153 SDCCAG10{serologically defined colon cancer antigen 10}rabbit.pAb 0.2ml
201-20-5154 SDCCAG3{serologically defined colon cancer antigen 3}rabbit.pAb 0.2ml
201-20-5155 SDCCAG8{serologically defined colon cancer antigen 8}rabbit.pAb 0.2ml
EIAAB29341 Cellular zinc finger anti-NF-kappa-B protein,Homo sapiens,Human,OTU domain-containing protein 7B,OTUD7B,ZA20D1,Zinc finger A20 domain-containing protein 1,Zinc finger protein Cezanne


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur